Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: William Ericson, David Botstein, Gavin Wood, Nicolas Cartier

Premium

Pacific Biosciences' shareholders have re-elected William Ericson and David Botstein to continue serving as members of its board of directors.

Botstein is director of the Lewis-Sigler Institute for Integrative Genomics and a professor at Princeton University, and he formerly was VP for science at Genentech. Ericson is a general partner at Mohr Davidow Ventures.


Affymetrix has named Gavin Wood as its new chief financial officer. He will replace outgoing CFO Tim Barabe, who is set to leave the company on June 28.

Wood has worked for Affymetrix for seven years. He will be relocating to California from the UK to take over as CFO. He most recently served as vice president of finance, international controller, where he was responsible for Europe and Asia Pacific. Wood is a chartered accountant and prior to joining Affymetrix, he held positions at Unipart and Grant Thornton LLP.


BioMérieux has appointed Nicolas Cartier to be corporate VP of its Industrial Microbiology Unit. He also will become a member of the company's management committee. Cartier has been general manager of Sanofi France since 2009, and he held a number of other posts with Sanofi in its Southeast Asia, China, and Mexico City operations.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.